2016
DOI: 10.1039/c5ra28187c
|View full text |Cite
|
Sign up to set email alerts
|

2-Amino-4-aryl thiazole: a promising scaffold identified as a potent 5-LOX inhibitor

Abstract: Human 5-lipoxygenase (5-LOX) is a target for asthma and allergy treatment. Zileuton is the only marketed drug targeting this enzyme (IC50 ∼ 1 μM). The current study identifies a promising lead molecule which could be improved to match the activity of zileuton.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 19 publications
(8 citation statements)
references
References 53 publications
0
8
0
Order By: Relevance
“…Compounds bearing thiazole and pyrazole nuclei are found to have various antimicrobial activities such as antibacterial, antifungal and antitumor [1][2][3][4][5][6][7]. The asymmetric unit (cf.…”
Section: Discussionmentioning
confidence: 99%
“…Compounds bearing thiazole and pyrazole nuclei are found to have various antimicrobial activities such as antibacterial, antifungal and antitumor [1][2][3][4][5][6][7]. The asymmetric unit (cf.…”
Section: Discussionmentioning
confidence: 99%
“…The alkaloids -Vasicine (98.2%) and Vasicinone (95.6%) (Natural Remedies, Bangalore, India) and control Zileuton (cayman chemical, Incalco, Italy) were subjected to an in-vitro 5-LOX enzyme inhibition assay as described by Sinha et al (2016). Semi-purified 5-LOX fraction extracted from the E.coli BL 21 bacteria containing pT3 plasmid coding recombinant human 5-LOX (Zhang et al, 1992) [a kind gift from Prof Olof Rådmark, Karolinska Institute, Stockholm, Sweden] was used in this assay.…”
Section: In-vitro Enzyme Inhibition Assaymentioning
confidence: 99%
“…In analogy to our previous study, it was possible to incorporate the chalcone group along with thiazole for 5-LOX inhibition with a synergistic effect. As a result, molecules ( 4k : IC 50 = 0.07 ± 0.02 μM, 4n : IC 50 = 0.08 ± 0.05 μM) synthesized here are found to be 10–100 times better potent than previously reported thiazole molecules ( 2m : IC 50 = 0.9 ± 0.1 μM, 1d : IC 50 = 10 μM) by us and also better than Zileuton (IC 50 = 1.05 ± 0.03 μM). , SAR indicated that the presence of a greater number of electron donating groups, namely, methoxy and methyl, either in the vicinity of chalcone or both thiazole and chalcone contributed a synergistic effect and yielded highly active molecules. Pharmacophore elucidation revealed that the double bond of chalcone is one of the important reasons for hydrophobic centroid generation for inhibition.…”
Section: Docking Studiesmentioning
confidence: 99%
“…Thiazoles are active constituents of various naturally occurring biologically significant compounds such as thiamine, mycothiazole, as well as synthetic drugs which act as antimicrobial, anti-inflammatory, anticancer, antiviral, and antitubercular. , Thiazol-4­(5H)-one derivatives, namely darbufelone and CI-987, are reported as dual COX/LOX inhibitors . Recently, thiazole bearing scaffolds, namely 2-amino-4-aryl thiazole-5-phenylmethanones, , N-aryl thiazole-2-amines, and 5-benzylidene-2-phenylthiazolinones, are identified as selective 5-LOX whereas aminothiazole pirinixic acids as dual 5-LOX/mPGES1 inhibitors.…”
mentioning
confidence: 99%